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To investigate the role that cardiac anomalies play in the significant regurgitation or stenosis in any subject. Of the 
early death frequently seen in the trisomy 13 and the four valves, the pulmonary valve, followed by the tricuspid 
trisomy 18 syndromes, two-dimensional and Doppler valve, was the most commonly dysplastic. Doppler evidence 
echocardiograms from 31 newborn infants with cytogenetic suggestive of elevated pulmonary artery pressure (low 
confirmation of these syndromes seen at one institution over velocity bidirectional flow across the ventricular septal 
a 4.5 year period (1983 to 1988) were reviewed. The mean defect and patent ductus arteriosus), although expected, 
age at echocardiography was 1.5 days, and the median age was accompanied by greater than normal mean right 
at death was 14 days. Significant cyanosis was present in ventricular cavity and free wall dimensions in these pa- 
58%. tients. 
Cardiac anomalies that would be considered lethal 
within the neonatal period were present in only 19% of 
patients. The most common lesions were atrial septal defect 
(81%), ventricular septal defect (61%) and patent ductus 
arteriosus (85%). Most ventricular septal defects and 
patent ductus arteriosi were large. Valvular dysplasia of 
one or more valves, graded as mild in most cases, was found 
in 68%, but was not associated with Doppler evidence of 
Thus, although the cardiac anomalies most frequently 
encountered in trisomy 13 and trisomy 18 are nonlethal, the 
combined findings of frequent cyanosis and increased right 
ventricular dimensions suggest that other factors such as 
pulmonary hypertension, perhaps related to maldevelop 
ment of the pulmonary vasculature, may contribute to early 
death in some of these infants. 
(J Am Co11 Cardiol1990;15:673-7) 
Congenital cardiovascular anomalies are extremely common 
in the trisomy 13 and the trisomy 18 syndromes, in addition 
to other anomalies involving the urogenital and central 
nervous systems (l-7). Although the spectrum of cardiovas- 
cular anomalies associated with these syndromes has been 
extensively described (8-12), all the information has been 
based on autopsy studies. Most recently, in a detailed 
analysis of 41 cases of trisomy 18, Van Praagh et al. (12) 
speculated that fetal echocardiographic diagnosis of this 
syndrome may be possible on the basis of the characteristic 
cardiac lesions. However, the echocardiographic appear- 
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ante of these cardiac lesions, particularly that of the ubiq- 
uitous valvular dysplasia, and their functional consequences 
during life have not been addressed. Indeed, although con- 
gestive heart failure is considered to be one of the major 
causes of death in these infants (5,7). there is no direct 
evidence that this is so. Thus, the effect that congenital 
cardiovascular anomalies may have on longevity in these 
syndromes remains unclear. In this study, we evaluated the 
echocardiograms from a group of infants with cytogeneti- 
tally confirmed trisomy 13 or 18 in an attempt to correlate 
the reported pathologic findings with echocardiographic 
anatomy and function. 
Methods 
Study patients. The records of all newborn infants seen at 
the Hospital for Sick Children between January 1983 and 
April 1988 with clinical features and cytogenetic confirma- 
tion of trisomy 13 or 18 were examined. All such infants 
transferred to this center from institutions within the south- 
0735-1097190153.50 
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western Ontario region are evaluated by a team of neonatol- 
ogists and geneticists. In addition to evaluation for major 
congenital anomalies, which includes cardiac ultrasound 
examination, G-banded karyotypes are obtained using stan- 
dard culture and staining techniques (13,14). Infants are 
returned to the referring centers once evaluation is com- 
plete. 
Echocardiography. During the 4.5 year study period, 32 
newborns with the diagnosis of trisomy 13 (n = 14, 8 male, 
6 female) or trisomy 18 (n = 18, 9 male, 9 female were 
transferred to the Hospital for Sick Children for evaluation 
of multiple congenital anomalies or dysmorphism. Of these, 
30 had echocardiograms performed at a mean age of 1.5 
days, and 1 infant in whom the diagnosis of trisomy 18 had 
been made in the newborn period had the first echocardio- 
gram performed at age 3 months. These 31 patients make up 
the study group. The remaining infant’s echocardiogram was 
not available for review. 
Age at presentation, age at death and symptoms related to 
the cardiovascular system were obtained from the patients 
hospital records. Echocardiograms were reviewed; all had 
been performed according to a standard segmental protocol 
in all cases since 1983, utilizing high resolution 7.5 MHz 
transducers (ATL Mark 600 and Ultramark 8 ultrasound 
systems). The situs and atrioventricular and ventriculoarte- 
rial connections were evaluated. Valvular dysplasia was 
arbitrarily graded from 0 (normal) through grades 1 to 3 for 
mild, moderate or severe dysplasia, respectively, on the 
basis of echocardiographic tissue thickness and amount of 
accessory tissue tags. Dysplasia was termed severe only 
when associated with significant valvular stenosis or regur- 
gitation. Functional assessment included Doppler pressure 
gradients to evaluate valvular stenosis and quantitation of 
regurgitation as mild, moderate or severe on the basis of 
pulsed Doppler criteria (15). Right ventricular end-diastolic 
dimension and free wall thickness were measured from 
M-mode or two-dimensional images. All echocardiograms 
were of sufficiently good quality to allow complete assess- 
ment. 
Results 
Clinical features. Symptoms in the 31 newborns included 
significant cyanosis in 18 (58%). Fourteen required intuba- 
tion and ventilation for cyanosis or other respiratory symp- 
toms. The mean age at death was 45 days (range 1 day to 10 
months), although the median age was much lower (14 days). 
Only six infants (19%) had immediately lethal cardiac anom- 
alies (one with aortic atresia, two with coarctation of the 
aorta and three with pulmonary atresia) (Table 1). One of 
these patients had undergone a Blalock-Taussig shunt for 
pulmonary atresia with intact ventricular septum before the 
result of chromosomal analysis was available. Only one 
infant with an isolated atria1 septal defect and mild dysplasia 
Table 1. Cardiac Lesion by Chromosomal Anomaly in 31 
Newborns With Trisomy 13 or Trisomy 18 
Cardiac Anomaly 
Trisomy 13 Trisomy 18 
(n = 14) (n = 17) 
ASD 12 (85%) 13 (76%) 
PDA 8 (57%) I5 (88%) 
VSD 6 (42%) 13 (76%) 
Bicuspid aortic valve 0 6 (35%) 
Aortic coarctation 0 2 (12%) 
Complex lesions 4 (30%) 4 (24%) 
PATNSD 1 PATIIVS 1 
ToF 1 AVSD/coarct 1 
DextrolAVSDiaortic atresia 1 DORVlMA 1 
AVSDIPAT 1 DORVlPS 1 
ASD = atria1 septal defect; AVSD = atrioventricular septal defect; coarct 
= coarctation of aorta; Dextro = dextrocardia; DORV = doublet outlet right 
ventricle; IVS = intact ventricular septum; MA = mitral atresia; PAT = 
pulmonary atresia; PDA = patent ductus arteriosus; PS = pulmonary steno- 
sis; ToF = tetralogy of Fallot; VSD = ventricular septal defect. 
of the tricuspid and pulmonary valves is still alive at age 4 
years, 
Echocardiographic evaluation. Table 1 lists the cardiac 
lesions according to chromosome anomaly. All patients had 
situs solitus. The frequency of the various lesions is similar 
to that reported in other series (8,lO). A minority (19%) of 
infants had life-threatening cardiac lesions that required 
immediate palliation or repair in the newborn period for 
survival. 
The ventricular septal defect was large in virtually all 
cases (Fig. I), extending from the perimembranous area into 
the inlet (n = 5) and outlet (n = 12) muscular ventricular 
septum, with slight malalignment between the ventricular 
and infundibular septum in all the latter cases. Two cases 
showed aneurysmal tissue around the ventricular septal 
defect, which herniated through the defect into the left 
ventricular outflow tract in systole. In neither case, how- 
ever, was a pressure gradient present across the left ventric- 
ular outflow tract. 
Most atria1 septal defects were moderate in size, and a 
significant proportion had flaps of tissue within them. A large 
patent ductus arteriosus was present in 85% of patients, 
being slightly more frequent in trisomy 18 than in trisomy 13. 
Valvular dysplasia. There was a remarkable absence of 
valvular regurgitation and stenosis despite the dysplasia of 
one or more valves in 21 patients. Dysplasia was more 
common in trisomy 18 than in trisomy 13. The pulmonary 
valve was the most commonly involved valve; the tricuspid 
valve was the next most commonly involved (Table 2). In 
most cases, the degree of dysplasia was considered mild 
(Fig. 1). Mean pulmonary (10 mm, range 7 to 12) and aortic 
(8.5 mm, range 7.5 to 12) anulus diameters were normal 
compared with values reported for normal newborns (16,17) 
in all except the eight patients with complex lesions associ- 
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Figure 1. Typical ventricular septal defect seen in patients with 
trisomy 13 or trisomy 18 in parasternal long- (a) and short- (b) axis 
views. a, The defect in this patient with trisomy 18 is large (arrows), 
involving the membranous and anterior muscular septum, with mild 
malalignment. Note the right ventricular (RV) anterior wall is 
thicker than the left ventricular (LV) posterior wall. The right 
ventricular cavity is also enlarged. b, This parasternal short-axis 
view in a patient with trisomy 13 shows very redundant thickened 
tricuspid valve leaflets (small arrows), a moderately large ventricular 
septal defect (medium size arrows) and a thickened doming pulmo- 
nary valve (large arrows) with a normal size valve anulus. There was 
no Doppler gradient across the pulmonary valve. a = anterior: Ao = 
aorta; i = inferior; la = left atrium; mpa = main pulmonary artery: 
p = posterior; ra = right atrium; s = superior. 
ated with pulmonary or aortic stenosis or atresia (n = 8). 
Valvular dysplasia was, therefore, not associated with an- 
nular hypoplasia. 
Right ventricular dimensions. Mean right ventricular end- 
diastolic dimensions and right ventricular free wall thickness 
measured in the parasternal short-axis view were increased 
(9.5 versus 8 mm and 4.5 versus 3 mm, respectively) 
compared with the reported normal values in newborns (18). 
Doppler evaluation. Evaluation of flow across the ven- 
tricular septal defect showed low velocity bidirectional flow, 
Table 2. Valvular Dysplasia in 31 Newborns With Trisomies 
13 and 18 
Dysplasia Grade 
Valve No. 0 1 2 3 Stenosis Regurgitation 
Trisomy 13 











1 13 l-- - - 
2 122-- - - 
4 10 3 1 - - 3 
6 842- - - 
6 II 4 2 - - - 
3 14 2 1 - - - 
11 6 IO 1 - 2* 1 
6 11 3 3 - - 1 
*Excludes the four patients with semilunar valve atresia and the one with 
tetralogy of Fallot. Altogether 21 patients (68%) had dysplasia of one or more 
valves. The mitral valves in three patients (one with trisomy 13. two with 
trisomy 18) had a single papillary muscle (parachute deformity), but were 
neither stenotic nor regurgitant. The pulmonary valve was the most frequently 
involved in patients with trisomy 18. Echocardiographic grading of dysplasia 
as mild (grade 1) moderate (grade 2) and severe (grade 3) was arbitrarily based 
on the valve tissue thickness and amount of accessory tissue tags. Significant 
stenosis or regurgitation was infrequent. Pressure gradients across the pul- 
monary valve in the two patients with stenosis (15 mm Hg) were small. 
a finding consistent with right ventricular and pulmonary 
artery pressures at systemic levels. Of the patients with 
Doppler evaluation of patent ductus arteriosus flow, 11 had 
bidirectional shunting and 5 had pure left to right shunting 
but of a low velocity (equivalent to < 10 mm Hg peak ductal 
gradient). One patient with aortic atresia had only right to 
left ductal shunting. 
Discussion 
Since the original descriptions of trisomy 13 (Patau syn- 
drome) (2) and trisomy 18 (Edwards syndrome) (l), multiple 
autopsy studies (3-12) have documented that cardiovascular 
anomalies are present with a consistently high frequency in 
these syndromes. Among the more common anomalies are 
ventricular septal defect, atria1 septal defect, patent ductus 
arterious and valvular dysplasia involving both atrioventric- 
uiar and semilunar valves. Rarer lesions include complex 
forms of double outlet right ventricle (8), atrioventricular 
septal defect and pulmonary atresia (4). Although the fre- 
quency of these various anomalies derived from pooled data 
is well established (7), echocardiographic description of the 
spectrum of cardiac lesions in a series of affected infants has 
not been carried out. The hemodynamic consequences re- 
sulting from the more common lesions and their influence on 
the life span of affected infants are likewise unclear. Indeed, 
congestive heart failure is commonly believed to be one of 
the major causes of early death in these infants (5,7). 
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The combined frequency of cardiac anomalies in this 
study was virtually lOO%, when minor lesions such as 
bicuspid aortic valve and atria1 septal defects (some of which 
might very well close spontaneously with time) were consid- 
ered. The frequency of each anomaly also closely reflects 
published data (8,10). 
Ventricular septal defect. All but two of the ventricular 
septal defects were large, extending from the perimembra- 
nous into the inlet and outlet muscular septum in most cases, 
consistent with described pathologic features (12). This type 
of defect is highly unlikely to undergo spontaneous closure 
or diminution in size (19). 
Pulmonary hypertension. The majority of patent ductus 
arteriosi were also large. The finding of bidirectional shunt- 
ing by pulsed Doppler ultrasound across the ventricular 
septal defect and patent ductus arteriosus in these cases is 
consistent with the presence of pulmonary hypertension 
(19), an expected finding in infants with unrestrictive ven- 
tricular septal defect or patent ductus arteriosus. The un- 
usual finding, however, was the significantly greater right 
ventricular cavity dimensions and free wall thickness. Sim- 
ilar degrees of dilation and hypertrophy of the right ventricle 
are not usually seen in other newborns with uncomplicated 
ventricular septal defect or patent ductus arteriosus. The 
larger right ventricular cavity and free wall thickness cannot, 
therefore, be entirely explained by these lesions alone. 
These findings, together with the frequent presence of sig- 
nificant cyanosis in these infants, suggest that an excessive 
degree of pulmonary hypertension, perhaps related to pul- 
monary vascular abnormalities, may result in intracardiac 
right to left shunting and play a significant role in those 
infants who die early in the newborn period. In support of 
this, Van Praagh et al. (12) recently reported excessive 
muscularization of pulmonary arterioles in a subset of in- 
fants with trisomy 18 who died at <2 months of age. 
Additionally, many reports (7,21) mention abnormal right 
atria1 and ventricular enlargement at autopsy in late postna- 
tal deaths, further suggesting an unusually rapid progression 
of pulmonary hypertension. A similar rapid progression of 
pulmonary hypertension has been described (22) in infants 
with trisomy 21 and atria1 and ventricular septal defects, 
where multiple causes, including abnormal pulmonary arte- 
rial development, have been implicated. It is also of interest 
that valvular dysplasia usually associated with significant 
regurgitation is commonly seen with congenital cardiac 
anomalies in trisomy 21. 
Valvular dysplasia. Valvular dysplasia has been consid- 
ered a hallmark of the cardiac abnormalities in trisomies 13 
and 18 (9JO). Despite similar findings in this study in which 
dysplasia was arbitrarily graded by the echocardiographic 
appearance of valve leaflet thickness, there was neither 
significant regurgitation nor stenosis of the atrioventricular 
and semilunar valves. Thus, although we did not carry out a 
direct echocardiographic-pathologic correlation of valvular 
dysplasia in this study, the important significant finding was 
the lack of valvular stenosis or regurgitation, regardless of 
the grading of dysplasia. Additionally, in contrast to classic 
semilunar valve dysplasia encountered in infants presenting 
with significant pulmonary or aortic stenosis, which is usu- 
ally accompanied by significant annular hypoplasia, the anuli 
in the group of newborns in this study were within the 
normal range or larger. Although valvular dysplasia is as 
common at echocardiographic as it is at pathologic evalua- 
tion, the functional consequences during life resulting from 
this dysplasia appear to be insignificant in the majority of 
cases. This would suggest a relatively benign short-term 
course, with little if any hemodynamic compromise as a 
result of valvular dysplasia. 
Implications for fetal echocardiography. The recent ad- 
vent of high resolution fetal cardiac ultrasound has enabled 
diagnosis of many forms of congenital heart disease as early 
as the 16th week of gestation. The spectrum and severity of 
cardiac disease seen in early fetal life may be different from 
that seen postnatally (23), perhaps related to an attrition 
effect whereby survival to term is more likely in those with 
less severe defects. Despite the significant advances in 
ultrasound imaging, accurate delineation of cardiac anatomy 
still suffers from limitations related to image resolution and 
the limited number of tomographic planes available in utero. 
Thus, although we agree with Van Praagh et al. (12) that 
diagnosis of trisomy 18 early in utero on the basis of cardiac 
imaging may be possible, its role may depend more on 
recognition of characteristic valvular dysplasia in utero than 
on the appearance of the ventricular septal defect, which 
may be difficult to define. Our experience suggests that 
postnatally, valvular dysplasia can be readily recognized by 
two-dimensional echocardiography in these syndromes. 
Whether this will be the case in utero as well remains to be 
seen. 
Conclusions. The echocardiographic findings in this un- 
selected group of newborns with trisomy 13 or trisomy 18 
should complement those in other reports based on autopsy 
findings, and put into perspective the functional conse- 
quences of the common cardiac anomalies in these autoso- 
ma1 aneuploidies. In contrast to other newborns with atria1 
and ventricular septal defects or patent ductus arteriosus, 
newborns with trisomy 13 or trisomy 18 and these lesions die 
early of other complications. We speculate that developmen- 
tal pulmonary vascular abnormalities may result in severe 
pulmonary hypertension, in part explaining the high preva- 
lence of cyanosis and early death. Valvular dysplasia in the 
absence of complex cardiac lesions has no significant hemo- 
dynamic consequences over the short life span of these 
infants. The management of the minority of infants with 
these trisomy syndromes and life-threatening cardiac disease 
such as aortic or pulmonary atresia still rests on rapid 
confirmation of the chromosomal abnormality. 
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